USD 0.0
(-50.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | 3.72 Million USD | -49.75% |
2021 | 7.41 Million USD | 1258.88% |
2020 | 545.87 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 2.34 Million USD | -21.97% |
2023 Q1 | 2.99 Million USD | -19.53% |
2023 Q3 | 3.07 Million USD | 31.27% |
2022 Q3 | 4.93 Million USD | -19.47% |
2022 Q2 | 6.13 Million USD | 23.59% |
2022 Q1 | 4.96 Million USD | -33.13% |
2022 FY | 3.72 Million USD | -49.75% |
2022 Q4 | 3.72 Million USD | -24.51% |
2021 Q1 | - USD | 0.0% |
2021 FY | 7.41 Million USD | 1258.88% |
2021 Q4 | 7.41 Million USD | -93.11% |
2021 Q3 | 107.67 Million USD | 0.0% |
2020 FY | 545.87 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
America Great Health | 299.12 Thousand USD | -1145.989% |
Ampio Pharmaceuticals, Inc. | 5.73 Million USD | 35.022% |
Aridis Pharmaceuticals, Inc. | 14.69 Million USD | 74.637% |
Biora Therapeutics, Inc. | 31.21 Million USD | 88.06% |
Bio-Path Holdings, Inc. | 3.22 Million USD | -15.749% |
Better Therapeutics, Inc. | 22.94 Million USD | 83.755% |
Calithera Biosciences, Inc. | 28.67 Million USD | 87.003% |
Gene Biotherapeutics, Inc. | - USD | -Infinity% |
eFFECTOR Therapeutics, Inc. | 20.54 Million USD | 81.858% |
Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | 82.355% |
Evelo Biosciences, Inc. | 64.44 Million USD | 94.216% |
Evolutionary Genomics, Inc. | 2.35 Million USD | -58.351% |
Finch Therapeutics Group, Inc. | 70.99 Million USD | 94.75% |
Galera Therapeutics, Inc. | 26.14 Million USD | 85.742% |
Innovation1 Biotech Inc. | 75.99 Thousand USD | -4804.548% |
Kiromic BioPharma, Inc. | 12.16 Million USD | 69.372% |
Molecular Templates, Inc. | 35.38 Million USD | 89.466% |
Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | 14.743% |
NexImmune, Inc. | 8.59 Million USD | 56.631% |
Orgenesis Inc. | 14.55 Million USD | 74.388% |
Panbela Therapeutics, Inc. | 11.8 Million USD | 68.42% |
Point of Care Nano-Technology, Inc. | 124.64 Thousand USD | -2890.23% |
PaxMedica, Inc. Common Stock | 5.68 Million USD | 34.386% |
Scopus BioPharma Inc. | 392.26 Thousand USD | -850.152% |
Sorrento Therapeutics, Inc. | 472.84 Million USD | 99.212% |
Statera Biopharma, Inc. | 21.16 Million USD | 82.394% |
TRACON Pharmaceuticals, Inc. | 10.1 Million USD | 63.116% |
Trevena, Inc. | 40.6 Million USD | 90.821% |
Vaxxinity, Inc. | 44.35 Million USD | 91.597% |
Vaccinex, Inc. | 3.63 Million USD | -2.647% |
Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -9298.611% |
Viracta Therapeutics, Inc. | 56.69 Million USD | 93.426% |
ZIVO Bioscience, Inc. | 555.71 Thousand USD | -570.688% |